PureTech Health plc (NASDAQ:PRTC – Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $28.79, but opened at $27.64. PureTech Health shares last traded at $27.64, with a volume of 150 shares traded.
PureTech Health Price Performance
The company’s 50-day moving average is $28.37 and its two-hundred day moving average is $25.93.
Hedge Funds Weigh In On PureTech Health
A hedge fund recently bought a new stake in PureTech Health stock. AWM Investment Company Inc. bought a new stake in PureTech Health plc (NASDAQ:PRTC – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 6,900 shares of the company’s stock, valued at approximately $197,000. 0.04% of the stock is currently owned by institutional investors and hedge funds.
About PureTech Health
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Recommended Stories
- Five stocks we like better than PureTech Health
- 3 REITs to Buy and Hold for the Long Term
- Signet Jewelers Stock Poised for Rebound After Earnings Drop
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Airship AI Lands New Contract: Stock Soars 16% and More to Come
- How to Invest in Blue Chip Stocks
- Restoration Hardware Stock: Should You Buy After Earnings Drop?
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
